The targeted localization of maximal concentrations of the therapeutic to the cellular/subcellular site of action in pathologically damaged tissues is one of the recurring obstacles in therapeutic drug delivery. Small molecule medications lack tissue and organ selectivity, have quick in vivo body clearance, and are frequently associated with a slew of adverse effects, particularly chemotherapeutic treatments, which are extremely toxic. Drug delivery systems (DDS) have been employed as one of the most promising solutions to solve this issue in recent decades. Cell-mediated DDS has emerged as a promising technique for addressing the aforementioned issues in recent years. Cell-mediated DDS has emerged as a new branch of therapy that allows for tailored distribution, increased circulation time, and decreased cellular and tissue toxicity. Intracellular delivery/therapy is a critical topic that will pique people's curiosity. Because the drug is not provided externally within the bloodstream, intracellular delivery allows for far more efficient drug delivery because the impact (on various organelles and locations) is intracellular. Targeted delivery with increased localized delivery and efficacy has a lot of potential.
- Drug Targeting and Design
- Targeted Drug Delivery System
- Tissue Specific Drug Delivery
A C Matin
Stanford University, United States
Consolato M Sergi
Universities of Alberta and Ottawa, Canada
Luis Jesus Villarreal Gomez
Autonomous University of Baja California, Mexico
John K Maesaka
NYU Langone Hospital Long Island, United States
Richard Denk
SKAN AG, Switzerland
Peter B Chase
Essentia Health- St. Mary's Medical Center, United States
Saliha Koc Aslan
Acibadem Healthcare Group, Turkey
Ana Isabel Rocha Faustino
University of Evora, Portugal
Narapereddy Krishna Prasad
Reckitt Benckiser LLC, United States
Title : Extracellular vesicles as delivery vehicles of therapeutic compounds
Stefania Raimondo, University of Palermo, Italy
Title : EU GMP annex1 barrier system and PIC/s annex 2A on cell and gene therapy
Richard Denk, SKAN AG, Switzerland
Title : Role of nanoformulations in treating Cystic Fibrosis
Bhupendra Gopalbhai Prajapati, Ganpat University, India
Title : Dual GIP/GLP-1 receptor stimulation in treatment of type 2 diabetes mellitus – The ground-breaking 'twincretin' approach
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Pathology and patient safety: The vital role of electronic medical record and pathology informatics in error reduction and precision medicine
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : mRNA-based systemically delivered directed gene therapy using nanomaterials
A C Matin, Stanford University, United States
Title : Colon-specific scallop hydrolysates/Κ-carrageenan hydrogel loaded with curcumin alleviates dss-induced colitis through modulation of inflammatory cytokines and gut microbiota
Hai Tao Wu, Dalian Polytechnic University, China
Title : Mucoadhesive electrospun fibrous systems for the fast and sustained delivery of drugs
Luis Jesus Villarreal Gomez, Autonomous University of Baja California, Mexico
Title : General and local anaesthetic agents: An analysis of their safety data
Francesca Gargano, Campus Bio-Medico University of Rome, Italy
Title : 15,16-dihydrotanshinone-I-laden PLGA-co-PEG nanoparticles are potential therapeutic agents for the treatment of colorectal cancer by targeting the β-catenin/CD36 axis
Kwan Hiu Yee, Hong Kong Baptist University, China